XCath Funding

Funding

• 2026-03-12 - Series C - $30M - XCath secures $30M Series C to advance neuro-endovascular surgical robotics - source: businesswire.com
• 2022-01-01 - Series B - $24M - XCath $24M Series B (Crescent Enterprises 2022 report) - source: crescententerprises.com